JOHNS HOPKINS UNIVERSITY
π³π¦Namibia
- Country
- π³π¦Namibia
- Ownership
- -
- Established
- 1876-01-01
- Employees
- 19.4K
- Market Cap
- -
- Website
- https://www.jhu.edu/
Home Visits for Patients at Risk for Appointment No-shows
Not Applicable
Withdrawn
- Conditions
- Utilization, Health CareNo-Show PatientsEngagement, Patient
- Interventions
- Other: Home visit
- First Posted Date
- 2020-05-06
- Last Posted Date
- 2023-07-07
- Lead Sponsor
- Johns Hopkins University
- Registration Number
- NCT04376736
- Locations
- πΊπΈ
Johns Hopkins Outpatient Center, Baltimore, Maryland, United States
Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)
Phase 1
Completed
- Conditions
- SARS-CoV-2 Infection
- Interventions
- Biological: Anti-SARS-CoV-2 Human Convalescent Plasma
- First Posted Date
- 2020-05-06
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 14
- Registration Number
- NCT04377672
- Locations
- πΊπΈ
Johns Hopkins Hospitals, Baltimore, Maryland, United States
Reducing Readmission Rates by Providing a Comprehensive Transition Plan From Hospital to Home for Cardiac Surgery Patients.
Not Applicable
Completed
- Conditions
- Cardiac Surgery
- Interventions
- Behavioral: Home Visit
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2020-05-05
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 450
- Registration Number
- NCT04373850
High Risk Outpatient Intern-led Care (HeROIC) Clinic Initiative
Not Applicable
Withdrawn
- Conditions
- Risk ReductionEmergenciesComorbidities and Coexisting Conditions
- Interventions
- Other: High Risk Clinic
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2022-07-25
- Lead Sponsor
- Johns Hopkins University
- Registration Number
- NCT04375189
- Locations
- πΊπΈ
Johns Hopkins Outpatient Center, Baltimore, Maryland, United States
Mobile Behavioral Ecological Momentary Assessment and Intervention in Rakai, Uganda
Not Applicable
Completed
- Conditions
- Ecological Momentary Assessment and Intervention
- Interventions
- Behavioral: Ecological momentary assessment only
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 58
- Registration Number
- NCT04375423
Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic
Completed
- Conditions
- Ocular Infection, ViralConjunctivitisCOVID-19Ocular InflammationSARS-CoV-2
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 36
- Registration Number
- NCT04374656
- Locations
- πΊπΈ
Wilmer Eye Institute, Baltimore, Maryland, United States
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications
Phase 2
Completed
- Conditions
- SARS-CoV 2
- Interventions
- Biological: SARS-CoV-2 convalescent plasmaBiological: Plasma from a volunteer donor
- First Posted Date
- 2020-05-04
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 1225
- Registration Number
- NCT04373460
- Locations
- πΊπΈ
Western Connecticut Health Network, Danbury Hospital, Danbury, Connecticut, United States
πΊπΈWestern Connecticut Health Network, Norwalk Hospital, Norwalk, Connecticut, United States
πΊπΈNorthShore University HealthSystem, Evanston, Illinois, United States
Community Initiated Preventive Therapy for TB
Not Applicable
Completed
- Conditions
- Tuberculosis
- Interventions
- Other: Community-Based TPT Initiation
- First Posted Date
- 2020-04-30
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 1168
- Registration Number
- NCT04369326
- Locations
- πͺπΉ
KNCV-Ethiopia, Oromia Region, Oromia, Ethiopia
Prazosin to Prevent COVID-19 (PREVENT-COVID Trial)
- First Posted Date
- 2020-04-28
- Last Posted Date
- 2023-04-10
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 5
- Registration Number
- NCT04365257
- Locations
- πΊπΈ
Johns Hopkins Hospital, Baltimore, Maryland, United States
Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
Phase 2
Active, not recruiting
- Conditions
- Chronic Sinusitis
- Interventions
- Drug: placebo
- First Posted Date
- 2020-04-27
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 50
- Registration Number
- NCT04362501
- Locations
- πΊπΈ
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
Β© Copyright 2025. All Rights Reserved by MedPath